Accelerate development, reducing risks and costs, by optimising clinical studies with KerusCloud.
This uniquely powerful software simulates thousands of realistic clinical scenarios at a time, so every variable aspect of a study’s design can be fully optimised in silico.
Fast and cost-effective, KerusCloud ensures that only the best design is used for a real trial.
With KerusCloud multiple key aspects of a clinical study can be optimised rapidly including:
- Target population
- Study Design
- Analysis Strategy
- Success Criteria
KerusCloud addresses current development issues such as:
- Selecting the best development strategy
- Choosing between standard or complex innovative design trials such as adaptive platform trials (APTs), seamless studies, basket trials and umbrella trials
- Improving study success rates
- Identifying the best endpoint and patient subgroups
- Generating robust evidence packages for drug approval
- Supporting investment decisions
- Implementing Precision Medicine strategies
- Anonymising real-world data by generating realistic synthetic data
Optimising study design and analysis options with KerusCloud:
- Accelerates development by identifying the right development path, first time
- Increases real study success rates by 40%
- Generates more evidence for the same costs
- De-risks investment through rapid evaluation and testing of assumptions
- Adds value to current drug pipelines and existing data
For the best shot at success. Choose KerusCloud.